Overview
- SRx Health signed a definitive agreement to buy EMJ Crypto Technologies to reshape the public company around a Gen2 digital-asset treasury platform.
- The board unanimously approved the deal, which still requires SRx shareholder consent and customary closing conditions.
- EMJX’s system applies multi-asset allocation, AI- and quantitative models, and systematic hedging to manage treasury risk across cycles.
- Eric M. Jackson is slated to become CEO and chairman at closing, with the combined company planning to operate under the EMJX name and seek a ticker change.
- Benzinga reported SRXH jumped about 200% in premarket trading after the announcement, while shares will continue to trade under SRXH until completion expected in Q1 2026.